EDITORIAL
Published on 14 Jul 2023
Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
doi 10.3389/fonc.2023.1220063
- 1,652 views
- 5 citations
Articles
REVIEW
Published on 26 Apr 2023
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
doi 10.3389/fonc.2023.1166207
- 17,912 views
- 68 citations
ORIGINAL RESEARCH
Published on 20 Feb 2023
Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumors
doi 10.3389/fonc.2023.1105648
- 4,419 views
- 21 citations
ORIGINAL RESEARCH
Published on 20 Jan 2023
Multiomics integration reveals the effect of Orexin A on glioblastoma
doi 10.3389/fphar.2023.1096159
- 4,059 views
- 8 citations
MINI REVIEW
Published on 20 Dec 2022
Succinylation and redox status in cancer cells
doi 10.3389/fonc.2022.1081712
- 8,878 views
- 38 citations
